As we near the halfway point in 2021, having gone through over a year of the COVID-19 pandemic, GWHP Corp is excited about the progress the world has made with the current distribution and administering of the main vaccines, Moderna and Pfizer. However, even with much of the world continuing on the path towards re-opening and travel increasing, the use of PPE supplies and COVID-19 testing remains high.
Global WholeHealth Partners is in a position where our partnerships with key players allows us to continually source and supply these in demand products in wholesale quanties. While we are hopeful that with the vaccines currently being distributed and administered COVID-19 cases will begin to drop, we recognize that demand is still high for wholesale PPE supplies and wholesale COVID-19 diagnostic testing kits.
As we approach the half way mark of 2021, travel is beginning to increase steadily and more and more states are beginning to relax their social distancing and PPE requirements. However, it is important for us to remember that we are still in the middle of a pandemic. The use of PPE supplies such as masks and gloves as well as taking COVID-19 tests when we believe to have been exposed is the safest way to navigate the pandemic and protect the at risk community.
Global WholeHealth Partners stands committed to sourcing these in demand products for interested parties in wholesale capacities. Visit our medical supply page to view current offerings and get in touch with us to place your wholesale PPE supplies order, call 877-568-4947.
About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.